Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-κB signaling pathway in isoproterenol-induced myocardial hypertrophy

被引:104
作者
Yang, Juan [1 ,2 ]
Wang, Hong-Xin [1 ]
Zhang, Ying-Jie [2 ]
Yang, Yu-Hong [1 ]
Lu, Mei-Li [1 ]
Zhang, Jing [1 ]
Li, Sheng-Tao [1 ]
Zhang, Su-Ping [1 ]
Li, Guang [3 ]
机构
[1] Liaoning Med Coll, Inst Drug Res, Key Lab Cardiovasc & Cerebrovasc Drug Res Liaonin, Jinzhou 121001, Peoples R China
[2] Liaoning Med Coll, Affiliated Hosp 1, Jinzhou 121001, Peoples R China
[3] Liaoning Med Coll, Affiliated Hosp 5, Orthoped Surgeon Dept Cent Hosp Jinzhou City, Jinzhou 121001, Peoples R China
基金
中国国家自然科学基金;
关键词
Astragaloside IV; Isoproterenol; Myocardial hypertrophy; Inflammatory effect; TLR4/NF-kappa B; INDUCED CARDIAC-HYPERTROPHY; NF-KAPPA-B; VENTRICULAR MYOCYTES; EXPRESSION; RECEPTOR; RATS; ISOPRENALINE; ALPHA;
D O I
10.1016/j.jep.2013.10.017
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ethnopharmacological relevance: Astragaloside IV (As IV) is one of the main effective components isolated from the traditional Chinese medical herb Astragalus membranaceus. The protective effect of Astragalus membranaceus on myocardial hypertrophy has been extensively proved. To test the hypothesis that Astragaloside IV can ameliorate the myocardial hypertrophy and inflammatory effect induced by beta-adrenergic hyperactivity, we carried out in vivo and in vitro experiments. Material and methods: In in vivo study, the isoproterenol (Iso) (5 mg kg(-1) d(-1)) was used as a model of myocardial hypertrophy by intraperitoneal injection. SD rats were randomly assigned to following six groups: A: the control; B: Iso group; C: Iso plus As IV 20 mg kg(-1) d(-1); D: Iso plus As IV 40 mg kg(-1) d(-1); E: Iso plus As IV 80 mg kg(-1) d(-1); F: Iso plus Propranolol 40 mg kg(-1) d(-1). In in vitro study, cultured neonatal rat cardiomyocytes were pretreated with As IV (3, 10, 30 mu mol L-1), Propranolol (2 mu mol L-1) and BAY11-7082 (5 mu mol L-1) for 30 min, and then incubated with Iso (10 mu mol L-1) for 48 h. For the rats in each group, the heart mass index (HMI) and the left ventricular mass index (LVMI) were measured. To measure the transverse diameter of left ventricular myocardial cells (TDM), the hematoxylin-eosin (HE) staining method was applied. In addition, the volume and the total protein content of cardiomyocytes were measured, the mRNA expression of ANP and TLR4 were quantified by RT-PCR, the protein expression of TLR4, I kappa B alpha and p65 were quantified by Western blot, and the level of TNF-alpha and IL-6 were measured by ELISA. Results: In vivo: Comparing the Iso group to the control, the HML LVMI, TDM were significantly increased; the protein expression of TLR4 and p65 were increased, while the I kappa B alpha were decreased; the expression of ANP, TLR4 mRNA, and TNF-alpha, IL-6 in serum were significantly increased. These changes could be partly prevented by As IV and Pro. In vitro: the over-expression of the cell size, total protein content could remarkably down-regulated by As N and Pro, and the results of RT-PCR, Western blot and ELISA were similar to those of in vivo. Conclusions: The results of these studies indicate that Astragaloside IV has good protective effect on myocardial hypertrophy induced by isoproterenol. More specifically, the cardioprotection is related to inhibiting the TLR4/NF-kappa B signaling pathway and the attenuating inflammatory effect. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1062 / 1070
页数:9
相关论文
共 35 条
[1]
Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy [J].
Althurwi, Hassan N. ;
Tse, Mandy M. Y. ;
Abdelhamid, Ghada ;
Zordoky, Beshay N. M. ;
Hammock, Bruce D. ;
El-Kadi, Ayman O. S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (08) :1794-1807
[2]
Toll-Like Receptor 4 Stimulation Initiates an Inflammatory Response That Decreases Cardiomyocyte Contractility [J].
Avlas, Orna ;
Fallach, Reut ;
Shainberg, Asher ;
Porat, Eyal ;
Hochhauser, Edith .
ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (07) :1895-1909
[3]
β-adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB [J].
Chandrasekar, B ;
Marelli-Berg, FM ;
Tone, M ;
Bysani, S ;
Prabhu, SD ;
Murray, DR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (02) :304-311
[4]
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy [J].
Chen, Ping ;
Xie, Yeqing ;
Shen, E. ;
Li, Gary G. ;
Yu, Yong ;
Zhang, Cassie B. ;
Yang, Yingzhen ;
Zou, Yunzeng ;
Ge, Junbo ;
Chen, Ruizhen ;
Chen, Haozhu .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 658 (2-3) :168-174
[5]
Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats [J].
Chen, Xiang-Jian ;
Meng, Dan ;
Feng, Lin ;
Bian, Yun-Yun ;
Li, Ping ;
Yang, Di ;
Cao, Ke-Jiang ;
Zhang, Ji-Nan .
AMERICAN JOURNAL OF CHINESE MEDICINE, 2006, 34 (06) :1015-1025
[6]
TNF-α signal transduction in rat neonatal cardiac myocytes:: definition of pathways generating from the TNF-α receptor [J].
Condorelli, G ;
Morisco, C ;
Latronico, MVG ;
Claudio, PP ;
Dent, P ;
Tsichlis, P ;
Condorelli, G ;
Frati, G ;
Drusco, A ;
Croce, CM ;
Napoli, C .
FASEB JOURNAL, 2002, 16 (13) :1732-1737
[7]
The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy [J].
Ehrentraut, Heidi ;
Weber, Carolyn ;
Ehrentraut, Stefan ;
Schwederski, Markus ;
Boehm, Olaf ;
Knuefermann, Pascal ;
Meyer, Rainer ;
Baumgarten, Georg .
EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (06) :602-610
[8]
Post-infarct remodelling: contribution of wound healing and inflammation [J].
Frantz, Stefan ;
Bauersachs, Johann ;
Ertl, Georg .
CARDIOVASCULAR RESEARCH, 2009, 81 (03) :474-481
[9]
[顾洁莹 Gu Jieying], 2012, [中华高血压杂志, Chinese Journal of Hypertension], V20, P838
[10]
Adenosine Reduces Cell Surface Expression of Toll-Like Receptor 4 and Inflammation in Response to Lipopolysaccharide and Matrix Products [J].
Haas, Benjamin ;
Leonard, Frederique ;
Ernens, Isabelle ;
Rodius, Sophie ;
Vausort, Melanie ;
Rolland-Turner, Magali ;
Devaux, Yvan ;
Wagner, Daniel R. .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2011, 4 (06) :790-800